AVIENT CORP
10-Qs and 10-Ks
PROXIES
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________
FORM
10-Q
________________________________________________
(Mark One)
|
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
For the quarterly period ended
March 31, 2023
OR
|
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
For the transition period from
to
.
Commission file number
1-16091
________________________________________________
(Exact name of registrant as specified in its charter)
________________________________________________
|
|
|
||||||||||
| (State or other jurisdiction | (I.R.S. Employer Identification No.) | ||||||||||
| of incorporation or organization) | |||||||||||
|
|
|||||||||||
|
|
|
||||||||||
|
|
|||||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
Registrant’s telephone number, including area code:
(
440
)
930-1000
Former name, former address and former fiscal year, if changed since last report:
Not Applicable
_______________________________________________
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
☒
Yes
☐
No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
☒
Yes
☐
No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
☒ | Accelerated filer | ☐ | ||||||||
| Non-accelerated filer | ☐ | Smaller reporting company |
|
||||||||
| Emerging growth company |
|
||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
☐
Yes
☒
No
The number of the registrant’s outstanding common shares, par value $.01 per share, as of March 31, 2023 was
91,072,473
.
AVIENT CORPORATION
PART I — FINANCIAL INFORMATION
ITEM 1.
FINANCIAL STATEMENTS
Avient Corporation
Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
|
Three Months Ended
March 31, |
|||||||||||
| 2023 | 2022 | ||||||||||
| Sales | $ |
|
$ |
|
|||||||
| Cost of sales |
|
|
|||||||||
| Gross margin |
|
|
|||||||||
| Selling and administrative expense |
|
|
|||||||||
| Operating income |
|
|
|||||||||
| Interest expense, net |
(
|
(
|
|||||||||
| Other income (expense), net |
|
(
|
|||||||||
| Income from continuing operations before income taxes |
|
|
|||||||||
| Income tax expense |
(
|
(
|
|||||||||
| Net income from continuing operations |
|
|
|||||||||
| (Loss) income from discontinued operations, net of income taxes |
(
|
|
|||||||||
| Net income | $ |
|
$ |
|
|||||||
| Net income attributable to noncontrolling interests |
(
|
(
|
|||||||||
| Net income attributable to Avient common shareholders | $ |
|
$ |
|
|||||||
| Earnings (loss) per share attributable to Avient common shareholders - Basic | |||||||||||
| Continuing operations | $ |
|
$ |
|
|||||||
| Discontinued operations |
(
|
|
|||||||||
| Total | $ |
|
$ |
|
|||||||
| Earnings (loss) per share attributable to Avient common shareholders - Diluted | |||||||||||
| Continuing operations | $ |
|
$ |
|
|||||||
| Discontinued operations |
(
|
|
|||||||||
| Total | $ |
|
$ |
|
|||||||
| Weighted-average shares used to compute earnings per common share: | |||||||||||
| Basic |
|
|
|||||||||
| Dilutive impact of share-based compensation |
|
|
|||||||||
| Diluted |
|
|
|||||||||
| Anti-dilutive shares not included in diluted common shares outstanding |
|
|
|||||||||
| Cash dividends declared per share of common stock | $ |
|
$ |
|
|||||||
See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.
1 AVIENT CORPORATION
Avient Corporation
Consolidated Statements of Comprehensive Income (Unaudited)
(In millions)
|
Three Months Ended
March 31, |
|||||||||||
| 2023 | 2022 | ||||||||||
| Net income | $ |
|
$ |
|
|||||||
| Other comprehensive income (loss), net of tax: | |||||||||||
| Translation adjustments and related hedging instruments |
|
(
|
|||||||||
| Cash flow hedges |
|
|
|||||||||
| Other |
(
|
|
|||||||||
| Total other comprehensive income (loss) |
|
(
|
|||||||||
| Total comprehensive income |
|
|
|||||||||
| Comprehensive income attributable to noncontrolling interests |
(
|
(
|
|||||||||
| Comprehensive income attributable to Avient common shareholders | $ |
|
$ |
|
|||||||
See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.
2 AVIENT CORPORATION
Avient Corporation
Condensed Consolidated Balance Sheets
(In millions)
|
(Unaudited) March 31, 2023
|
December 31, 2022 | ||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
| Accounts receivable, net |
|
|
|||||||||
| Inventories, net |
|
|
|||||||||
| Other current assets |
|
|
|||||||||
| Total current assets |
|
|
|||||||||
| Property, net |
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Intangible assets, net |
|
|
|||||||||
| Other non-current assets |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Short-term debt | $ |
|
$ |
|
|||||||
| Accounts payable |
|
|
|||||||||
| Accrued expenses and other current liabilities |
|
|
|||||||||
| Total current liabilities |
|
|
|||||||||
| Non-current liabilities: | |||||||||||
| Long-term debt |
|
|
|||||||||
| Pension and other post-retirement benefits |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Other non-current liabilities |
|
|
|||||||||
| Total non-current liabilities |
|
|
|||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Avient shareholders’ equity |
|
|
|||||||||
| Noncontrolling interest |
|
|
|||||||||
| Total equity |
|
|
|||||||||
| Total liabilities and equity | $ |
|
$ |
|
|||||||
See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.
3 AVIENT CORPORATION
Avient Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
|
Three Months Ended
March 31, |
|||||||||||
| 2023 | 2022 | ||||||||||
| Operating Activities | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation and amortization |
|
|
|||||||||
| Accelerated depreciation |
|
|
|||||||||
| Share-based compensation expense |
|
|
|||||||||
| Changes in assets and liabilities, net of the effect of acquisitions: | |||||||||||
| Increase in accounts receivable |
(
|
(
|
|||||||||
| Decrease (increase) in inventories |
|
(
|
|||||||||
| (Decrease) increase in accounts payable |
(
|
|
|||||||||
| Accrued expenses and other assets and liabilities, net |
(
|
(
|
|||||||||
| Net cash (used) provided by operating activities |
(
|
|
|||||||||
| Investing activities | |||||||||||
| Capital expenditures |
(
|
(
|
|||||||||
| Net proceeds from divestiture |
|
|
|||||||||
| Net cash used by investing activities |
(
|
(
|
|||||||||
| Financing activities | |||||||||||
| Purchase of common shares for treasury |
|
(
|
|||||||||
| Cash dividends paid |
(
|
(
|
|||||||||
| Repayment of long-term debt |
(
|
(
|
|||||||||
| Other financing |
(
|
(
|
|||||||||
| Net cash used by financing activities |
(
|
(
|
|||||||||
| Effect of exchange rate changes on cash |
|
(
|
|||||||||
| Decrease in cash and cash equivalents |
(
|
(
|
|||||||||
| Cash and cash equivalents at beginning of year |
|
|
|||||||||
| Cash and cash equivalents at end of period | $ |
|
$ |
|
|||||||
See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.
4 AVIENT CORPORATION
Avient Corporation
Consolidated Statements of Shareholders' Equity (Unaudited)
(In millions)
| Common Shares | Shareholders’ Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Common
Shares |
Common
Shares Held in Treasury |
Common
Shares |
Additional
Paid-in Capital |
Retained Earnings |
Common
Shares Held in Treasury |
Accumulated
Other Comprehensive (Loss) Income |
Total Avient shareholders' equity | Non-controlling Interests |
Total
equity |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at January 1, 2023 |
|
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — |
|
— | — |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — | — |
|
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash dividends declared | — | — | — | — |
(
|
— | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation and exercise of awards | — | — | — |
|
— |
|
— |
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2023 |
|
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||
| Common Shares | Shareholders’ Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Common
Shares |
Common
Shares Held in Treasury |
Common
Shares |
Additional
Paid-in Capital |
Retained Earnings |
Common
Shares Held in Treasury |
Accumulated
Other Comprehensive (Loss) Income |
Total Avient shareholders' equity | Non-controlling Interests |
Total
equity |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at January 1, 2022 |
|
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — |
|
— | — |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash dividends declared | — | — | — | — |
(
|
— | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common shares | — |
(
|
— | — | — |
(
|
— |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation and exercise of awards | — |
|
— |
(
|
— |
|
— |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2022 |
|
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||
See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.
5 AVIENT CORPORATION
Avient Corporation
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note 1 — BASIS OF PRESENTATION
Accounting Standards Adopted
Accounting Standards Update (ASU) 2022-04,
Liabilities - Supplier Finance Programs
(Subtopic 405-50)
,
provides guidance that requires entities that use supplier finance programs in connection with the purchase of goods and services to disclose the key terms of the program and information about their obligations that are outstanding at the end of the reporting period. The Company has evaluated the impact of adopting this standard and has concluded that there is not material activity under supplier finance programs that would require disclosure within the notes to the consolidated financial statements.
Note 2 — BUSINESS COMBINATIONS
On September 1, 2022, the Company completed the acquisition of the DSM Protective Materials business, including the Dyneema® brand, the World's Strongest Fiber™. The ultra-light specialty fiber is used in demanding applications such as ballistic personal protection, marine and sustainable infrastructure, renewable energy, industrial protection and outdoor sports. The acquired business is collectively referred to as APM, and the acquisition is referred to as the APM Acquisition. The APM Acquisition enhances Avient's material offerings of composites and engineered fibers, and results are recognized within the Specialty Engineered Materials segment.
Total consideration paid by the Company to complete the APM Acquisition was $
1.4
billion, net of cash acquired.
The APM Acquisition is being accounted for under the acquisition method of accounting in accordance with Financial Accounting Standards Board Accounting Standards Codification (ASC) Topic 805. As of March 31, 2023, the purchase accounting for the APM Acquisition is preliminary and purchase price allocation adjustments will be made through the end of the Company's measurement period, which is not to exceed one year from the acquisition date. During the measurement period, we will continue to obtain information to assist in finalizing the fair values of assets acquired as well as the associated deferred income taxes and residual goodwill, which may differ materially from the preliminary estimates. There were
no
measurement period adjustments recorded during the three months ended March 31, 2023.
6 AVIENT CORPORATION
The preliminary purchase price allocation is as follows:
| (in millions) | Preliminary Allocation | ||||
| Cash and cash equivalents | $ |
|
|||
| Accounts receivable |
|
||||
| Inventories |
|
||||
| Other current assets |
|
||||
| Property |
|
||||
| Intangible assets: | |||||
| Indefinite-lived trade names |
|
||||
| Customer relationships |
|
||||
| Patents, technology, and other |
|
||||
| Goodwill |
|
||||
| Other non-current assets |
|
||||
| Accounts payable |
|
||||
| Accrued expenses and other current liabilities |
|
||||
| Deferred tax liabilities |
|
||||
| Noncontrolling interests |
|
||||
| Other non-current liabilities |
|
||||
| Total purchase price consideration | $ |
|
|||
Definite-lived intangible assets that have been acquired have a preliminary useful life range of
17
to
20
years. Goodwill of $
396.5
million resulting from the acquisition was recorded to the Specialty Engineered Materials segment. The goodwill recognized is primarily attributable to intangible assets that do not qualify for separate recognition and the deferred tax impact of applying purchase accounting. Goodwill is not deductible for tax purposes.
Had the APM Acquisition occurred on January 1, 2021, sales and income from continuing operations before income taxes on a pro forma basis would have been as follows:
| Three Months Ended | |||||
| March 31, 2022 | |||||
| Sales | $ |
|
|||
| Income from continuing operations before income taxes |
|
||||
The unaudited pro forma financial information has been calculated after applying our accounting policies and adjusting the historical results with pro forma adjustments that assume the APM Acquisition occurred on January 1, 2021. These unaudited pro forma results do not represent financial results realized, nor are they intended to be a projection of future results.
Note 3 — DISCONTINUED OPERATIONS
On November 1, 2022, Avient sold its Distribution business to an affiliate of H.I.G. Capital (the Purchaser) for $
950.0
million in cash consideration, subject to a customary working capital adjustment. Total proceeds received were $
935.5
million, of which $
7.3
million was received in the period ended March 31, 2023. The results of the Distribution business are classified as discontinued operations for all periods presented.
7 AVIENT CORPORATION
|
Three Months Ended
March 31, |
|||||||||||
| (In millions) | 2023 | 2022 | |||||||||
| Sales | $ |
|
$ |
|
|||||||
| Cost of sales |
|
|
|||||||||
| Selling and administrative expense |
|
|
|||||||||
| Other expense |
|
|
|||||||||
| (Loss) income from discontinued operations before income taxes |
(
|
|
|||||||||
| Income tax expense |
|
(
|
|||||||||
| (Loss) income from discontinued operations, net of income taxes | $ |
(
|
$ |
|
|||||||
Note 4 — GOODWILL AND INTANGIBLE ASSETS
| (In millions) | Specialty Engineered Materials | Color, Additives and Inks | Total | ||||||||||||||
| Balance at December 31, 2022 | $ |
|
$ |
|
$ |
|
|||||||||||
| Currency translation |
|
|
|
||||||||||||||
| Balance at March 31, 2023 | $ |
|
$ |
|
$ |
|
|||||||||||
Indefinite and finite-lived intangible assets consisted of the following:
| As of March 31, 2023 | |||||||||||||||||||||||
| (In millions) | Acquisition Cost | Accumulated Amortization | Currency Translation | Net | |||||||||||||||||||
| Customer relationships | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
| Patents, technology and other |
|
(
|
|
|
|||||||||||||||||||
| Indefinite-lived trade names |
|
— |
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
| As of December 31, 2022 | |||||||||||||||||||||||
| (In millions) | Acquisition Cost | Accumulated Amortization | Currency Translation | Net | |||||||||||||||||||
| Customer relationships | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
| Patents, technology and other |
|
(
|
|
|
|||||||||||||||||||
| Indefinite-lived trade names |
|
— |
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
Note 5 —
EMPLOYEE SEPARATION AND RESTRUCTURING COSTS
We are engaged in a restructuring program associated with our integration of the Clariant Color Acquisition. These actions are expected to enable us to better serve customers, improve efficiency and deliver cost savings. We expect that the full restructuring plan will be implemented through 2024 and anticipate that we will incur approximately $
75.0
million of charges in connection with the restructuring plan. As of March 31, 2023, $
55.8
million has been incurred.
8 AVIENT CORPORATION
| (in millions) | Workforce reductions | Plant closing and other | Total | ||||||||||||||
| Balance at January 1, 2022 | $ |
|
$ |
|
$ |
|
|||||||||||
| Restructuring costs |
|
|
|
||||||||||||||
| Payments, utilization and translation |
(
|
(
|
(
|
||||||||||||||
| Balance at December 31, 2022 | $ |
|
$ |
|
$ |
|
|||||||||||
| Restructuring costs |
|
|
|
||||||||||||||
| Payments, utilization and translation |
(
|
(
|
(
|
||||||||||||||
| Balance at March 31, 2023 | $ |
|
$ |
|
$ |
|
|||||||||||
Additional headcount reductions were taken in the first quarter of 2023 as a result of global demand reductions, which resulted in a charge of $
14.1
million recorded during the three months ended March 31, 2023.
Note 6 — INVENTORIES, NET
Components of
Inventories, net
are as follows:
| (In millions) | As of March 31, 2023 | As of December 31, 2022 | |||||||||
| Finished products | $ |
|
$ |
|
|||||||
| Work in process |
|
|
|||||||||
| Raw materials and supplies |
|
|
|||||||||
| Inventories, net | $ |
|
$ |
|
|||||||
Note 7 — PROPERTY, NET
Components of
Property, net
are as follows:
| (In millions) | As of March 31, 2023 | As of December 31, 2022 | |||||||||
| Land and land improvements | $ |
|
$ |
|
|||||||
| Buildings |
|
|
|||||||||
| Machinery and equipment |
|
|
|||||||||
| Property, gross |
|
|
|||||||||
| Less accumulated depreciation |
(
|
(
|
|||||||||
| Property, net | $ |
|
$ |
|
|||||||
Note 8 — INCOME TAXES
During the three months ended March 31, 2023, the Company’s effective tax rate of
26.6
% was above the U.S. federal statutory rate of 21.0% primarily due to foreign withholding tax, tax on global intangible low-taxed income (GILTI), and an increase in foreign valuation allowances. These unfavorable items were partially offset by U.S. research and development credits, favorable foreign tax rate differential, and other favorable permanent tax items.
During the three months ended March 31, 2022, the Company’s effective tax rate of
23.5
% was above the U.S. federal statutory rate of 21.0% primarily due to foreign withholding tax, GILTI, and state taxes. These unfavorable items were also partially offset U.S. research and development credits, favorable foreign tax rate differential, and other favorable permanent tax items.
Note 9 — FINANCING ARRANGEMENTS
9 AVIENT CORPORATION
| As of March 31, 2023 (in millions) | Principal Amount | Unamortized discount and debt issuance cost | Net Debt | Weighted average interest rate | |||||||||||||||||||
| Senior secured revolving credit facility due 2026 | $ |
|
$ |
|
$ |
|
|
% | |||||||||||||||
| Senior secured term loan due 2026 |
|
|
|
|
% | ||||||||||||||||||
| Senior secured term loan due 2029 |
|
|
|
|
% | ||||||||||||||||||
|
|
|
|
|
|
% | ||||||||||||||||||
|
|
|
|
|
|
% | ||||||||||||||||||
| Other Debt |
|
|
|
||||||||||||||||||||
| Total Debt |
|
|
|
||||||||||||||||||||
| Less short-term and current portion of long-term debt |
|
|
|
||||||||||||||||||||
| Total long-term debt, net of current portion | $ |
|
$ |
|
$ |
|
|||||||||||||||||
| As of December 31, 2022 (in millions) | Principal Amount | Unamortized discount and debt issuance cost | Net Debt | Weighted average interest rate | |||||||||||||||||||
| Senior secured revolving credit facility due 2026 | $ |
|
$ |
|
$ |
|
|
% | |||||||||||||||
| Senior secured term loan due 2026 |
|
|
|
|
% | ||||||||||||||||||
| Senior secured term loan due 2029 |
|
|
|
|
% | ||||||||||||||||||
|
|
|
|
|
|
% | ||||||||||||||||||
|
|
|
|
|
|
% | ||||||||||||||||||
| Other Debt |
|
|
|
||||||||||||||||||||
| Total Debt |
|
|
|
||||||||||||||||||||
| Less short-term debt |
|
|
|
||||||||||||||||||||
| Total long-term debt, net of current portion | $ |
|
$ |
|
$ |
|
|||||||||||||||||
As of March 31, 2023, we had
no
borrowings outstanding under our senior secured revolving credit facility due 2026 (the Revolving Credit Facility), which had remaining availability of $
226.8
million.
The agreements governing our Revolving Credit Facility and our senior secured term loan, and the indentures and credit agreements governing other debt, contain a number of customary financial and restrictive covenants that, among other things, limit our ability to: sell or otherwise transfer assets, including in a spin-off, incur additional debt or liens, consolidate or merge with any entity or transfer or sell all or substantially all of our assets, pay dividends or make certain other restricted payments, make investments, enter into transactions with affiliates, create dividend or other payment restrictions with respect to subsidiaries, make capital investments and alter the business we conduct. As of March 31, 2023, we were in compliance with all covenants.
The estimated fair value of Avient’s debt instruments at March 31, 2023 and December 31, 2022 was $
2,192.6
million and $
2,153.1
million, respectively. The fair value of Avient’s debt instruments was estimated using prevailing market interest rates on debt with similar creditworthiness, terms and maturities and represent Level 2 measurements within the fair value hierarchy.
Note 10 — SEGMENT INFORMATION
Avient has
two
reportable segments: (1) Color, Additives and Inks and (2) Specialty Engineered Materials. Previously, Avient had
three
reportable segments; however, as a result of the divestiture of the Distribution business, we have removed Distribution as a separate reportable segment and its results are presented as a discontinued operation. Historical information has been retrospectively adjusted to reflect these changes. Refer to Note 3,
Discontinued Operations
for additional information. Operating income is the primary measure that is reported to our chief operating decision maker (CODM) for purposes of allocating resources to the segments and assessing their performance. Operating income at the segment level does not include: corporate general and administrative expenses that are not allocated to segments; intersegment sales and profit eliminations; charges related to specific strategic initiatives such as the consolidation of operations; restructuring activities, including employee separation costs resulting from personnel reduction programs, plant closure and phase-in costs; executive separation agreements; share-based compensation costs; asset impairments; environmental remediation costs, along with related gains from insurance recoveries, and other liabilities for facilities no longer owned or closed in prior years; actuarial gains and losses associated with our pension and other post-retirement benefit plans; and certain other items that are not included in the measure of segment profit or loss that is reported to and reviewed by our CODM. These costs are included in Corporate.
10 AVIENT CORPORATION
Segment information for the three months ended March 31, 2023 and 2022 is as follows:
|
Three Months Ended
March 31, 2023 |
Three Months Ended
March 31, 2022 |
|||||||||||||||||||||||||
| (In millions) | Sales |
Operating
Income |
Sales |
Operating
Income |
||||||||||||||||||||||
| Color, Additives and Inks | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Specialty Engineered Materials |
|
|
|
|
||||||||||||||||||||||
| Corporate |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Total Assets | |||||||||||
| (In millions) | As of March 31, 2023 | As of December 31, 2022 | |||||||||
| Color, Additives and Inks | $ |
|
$ |
|
|||||||
| Specialty Engineered Materials |
|
|
|||||||||
| Corporate |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
Note 11 — COMMITMENTS AND CONTINGENCIES
We have been notified by federal and state environmental agencies and by private parties that we may be a potentially responsible party (PRP) in connection with the environmental investigation and remediation of certain sites. While government agencies frequently assert that PRPs are jointly and severally liable at these sites, in our experience, the interim and final allocations of liability costs are generally made based on the relative contribution of waste. We may also initiate corrective and preventive environmental projects of our own to support safe and lawful activities at our operations. We believe that compliance with current governmental regulations at all levels will not have a material adverse effect on our financial position, results of operations or cash flows.
In September 2007, the United States District Court for the Western District of Kentucky (Court) in the case of
Westlake Vinyls, Inc. v. Goodrich Corporation, et al
., held that Avient must pay the remediation costs at the former Goodrich Corporation Calvert City facility (now largely owned and operated by Westlake Vinyls, Inc. (Westlake Vinyls)), together with certain defense costs of Goodrich Corporation. The rulings also provided that Avient can seek indemnification for contamination attributable to Westlake Vinyls.
Following the rulings, the parties to the litigation agreed to settle all claims regarding past environmental costs incurred at the site. The settlement agreement provides a mechanism to pursue allocation of future remediation costs at the Calvert City site to Westlake Vinyls. We will adjust our accrual, in the future, consistent with any such future allocation of costs.
Additionally, we continue to pursue available insurance coverage related to this matter and recognize gains as we receive reimbursement.
The environmental obligation at the site arose as a result of an agreement between The B.F. Goodrich Company (n/k/a Goodrich Corporation) and our predecessor, The Geon Company, at the time of the initial public offering in 1993. Under the agreement, The Geon Company agreed to indemnify Goodrich Corporation for certain environmental costs at the site. Neither Avient nor The Geon Company ever operated the facility.
Since 2009, Avient, along with respondents Westlake Vinyls, and Goodrich Corporation, has worked with the United States Environmental Protection Agency (USEPA) to address the remedial activities at the site. The USEPA issued its Record of Decision (ROD) in September 2018, selecting a remedy consistent with our accrual assumptions. In April 2019, the respondents signed an Administrative Settlement Agreement and Order on Consent with the USEPA to conduct the remedial actions at the site. In February 2020, three companies signed the agreed Consent Decree and remedial action Work Plan, which received Federal Court approval in January 2021. Our current reserve totals $
102.0
million for this matter.
During the three months ended March 31, 2023, Avient recognized $
1.4
million related to environmental remediation costs, compared to $
2.0
million recognized during the three months ended March 31, 2022.
11 AVIENT CORPORATION
During the three months ended March 31, 2022, Avient received $
0.6
million of insurance recoveries. These expenses and insurance recoveries are included within
Cost of sales
within our Condensed Consolidated Statements of Income.
Our Condensed Consolidated Balance Sheets include accruals totaling $
111.5
million and $
118.3
million as of March 31, 2023 and
December 31, 2022, respectively, based on our estimates of probable future environmental expenditures relating to previously contaminated sites. These undiscounted amounts are included in
on the accompanying Condensed Consolidated Balance Sheets. The accruals represent our best estimate of probable future costs that we can reasonably estimate, based upon currently available information and technology and our view of the most likely remedy. Depending upon the results of future testing, completion and results of remedial investigation and feasibility studies, the ultimate remediation alternatives undertaken, changes in regulations, technology development, new information, newly discovered conditions and other factors, it is reasonably possible that we could incur additional costs in excess of the amount accrued at March 31, 2023. However, such additional costs, if any, cannot be currently estimated.
Avient is subject to a broad range of claims, administrative and legal proceedings such as lawsuits that relate to contractual allegations, tax audits, product claims, personal injuries, and employment related matters. Although it is not possible to predict with certainty the outcome or cost of these matters, the Company believes our current reserves are appropriate and these matters will not have a material adverse effect on the condensed consolidated financial statements.
Note 12 — DERIVATIVES AND HEDGING
We are exposed to market risks, such as changes in foreign currency exchange rates and interest rates. To manage the volatility related to these exposures we may enter into various derivative transactions. We formally assess, designate and document, as a hedge of an underlying exposure, the qualifying derivative instrument that will be accounted for as an accounting hedge at inception. Additionally, we assess both at inception and at least quarterly thereafter, whether the financial instruments used in the hedging transaction are effective at offsetting changes in either the fair values or cash flows of the underlying exposures. In accordance with ASU 2017-12,
Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities
(ASU 2017-12), that ongoing assessment will be done qualitatively for highly effective relationships.
As a means of mitigating the impact of currency fluctuations on our euro investments in foreign entities, we have executed cross currency swaps, in which we pay fixed-rate interest in euros and receive fixed-rate interest in U.S. dollars related to our future obligations to exchange euros for U.S. dollars. These cross currency swaps effectively convert a portion of our U.S. dollar denominated fixed-rate debt to euro denominated fixed-rate debt.
We currently hold cross currency swaps with a combined notional amount of €
1,467.2
million, maturing in May 2025 and €
900.0
million maturing in August 2027. We designated the cross currency swaps as net investment hedges of our net investment in our European operations under ASU 2017-12 and applied the spot method to these hedges. The changes in fair value of the derivative instruments that are designated and qualify as hedges of net investments in foreign operations are recognized within
Accumulated Other Comprehensive Income
(AOCI) to offset the changes in the values of the net investment being hedged. For the three months ended March 31, 2023, losses of $
29.5
million were recognized within translation adjustments in AOCI, net of tax, compared to a gain of $
6.8
million, net of tax, for the three months ended March 31, 2022. Net interest payments received reduce
Interest expense, net
within the Condensed Consolidated Statements of Income and resulted in interest income of $
9.7
million and $
5.6
million for the three months ended March 31, 2023 and 2022, respectively.
All of our derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy. We determine the fair value of our derivatives based on valuation methods, which project future cash flows and discount the future amounts to present value using market based observable inputs, including interest rate curves and foreign currency rates.
The fair value of derivative financial instruments recognized in the Condensed Consolidated Balance Sheets is as follows:
| (In millions) | Balance Sheet Location |
As of
March 31, 2023
|
As of December 31, 2022
|
||||||||||||||
| Liabilities | |||||||||||||||||
|
Net investment hedge
|
Other non-current liabilities | $ |
|
$ |
|
||||||||||||
12 AVIENT CORPORATION
ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Our Business
We are a premier formulator of specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world. Our products include specialty engineered materials, performance fibers, advanced composites, and color and additive systems. We are also a highly specialized developer and manufacturer of performance enhancing additives, liquid colorants and fluoropolymer and silicone colorants. Headquartered in Avon Lake, Ohio, we have manufacturing and warehouse across the globe. We provide value to our customers through our ability to link our knowledge of polymers and formulation technology with our manufacturing and supply chain capabilities to provide value-added solutions to designers, assemblers and processors of plastics. When used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “Avient” and the “Company” mean Avient Corporation and its consolidated subsidiaries.
Highlights and Executive Summary
Trends and Developments
APM Acquisition
On September 1, 2022, the Company completed the acquisition of the DSM Protective Materials business, including the Dyneema® brand, the World's Strongest Fiber™. The ultra-light specialty fiber is used in demanding applications such as ballistic personal protection, marine and sustainable infrastructure, renewable energy, industrial protection and outdoor sports. The acquired business is collectively referred to as Avient Protective Materials and APM. The APM Acquisition will enhance Avient's material offerings of composites and engineered fibers.
Distribution business sale
On November 1, 2022, Avient sold its Distribution business to an affiliate of H.I.G. Capital, (the "Purchaser") for $950.0 million in cash, subject to a customary working capital adjustment. Total proceeds received were $935.5 million, of which $7.3 million was received in the period ended March 31, 2023. The results of the Distribution business are presented as discontinued operations for all periods presented.
13 AVIENT CORPORATION
Results of Operations —
The three months ended March 31, 2023 compared to three months ended March 31, 2022:
| Three Months Ended March 31, | Variances — Favorable (Unfavorable) | ||||||||||||||||||||||
| (Dollars in millions, except per share data) | 2023 | 2022 | Change |
%
Change |
|||||||||||||||||||
| Sales | $ | 845.7 | $ | 892.2 | $ | (46.5) | (5.2) | % | |||||||||||||||
| Cost of sales | 598.1 | 637.8 | 39.7 | 6.2 | % | ||||||||||||||||||
| Gross margin | 247.6 | 254.4 | (6.8) | (2.7) | % | ||||||||||||||||||
| Selling and administrative expense | 190.5 | 152.2 | (38.3) | (25.2) | % | ||||||||||||||||||
| Operating income | 57.1 | 102.2 | (45.1) | (44.1) | % | ||||||||||||||||||
| Interest expense, net | (28.8) | (16.9) | (11.9) | (70.4) | % | ||||||||||||||||||
| Other income (expense), net | 0.7 | (0.6) | 1.3 | nm | |||||||||||||||||||
| Income from continuing operations before income taxes | 29.0 | 84.7 | (55.7) | (65.8) | % | ||||||||||||||||||
| Income tax expense | (7.7) | (20.0) | 12.3 | 61.5 | % | ||||||||||||||||||
| Net income from continuing operations | 21.3 | 64.7 | (43.4) | (67.1) | % | ||||||||||||||||||
| (Loss) income from discontinued operations, net of income taxes | (0.9) | 19.8 | (20.7) | nm | |||||||||||||||||||
| Net income | 20.4 | 84.5 | (64.1) | (75.9) | % | ||||||||||||||||||
| Net income attributable to noncontrolling interests | (0.5) | (0.3) | (0.2) | nm | |||||||||||||||||||
| Net income attributable to Avient common shareholders | $ | 19.9 | $ | 84.2 | $ | (64.3) | (76.4) | % | |||||||||||||||
| Earnings (loss) per share attributable to Avient common shareholders - Basic | |||||||||||||||||||||||
| Continuing operations | $ | 0.23 | $ | 0.70 | |||||||||||||||||||
| Discontinued operations | (0.01) | 0.22 | |||||||||||||||||||||
| Total | $ | 0.22 | $ | 0.92 | |||||||||||||||||||
| Earnings (loss) per share attributable to Avient common shareholders - Diluted | |||||||||||||||||||||||
| Continuing operations | $ | 0.23 | $ | 0.70 | |||||||||||||||||||
| Discontinued operations | (0.01) | 0.21 | |||||||||||||||||||||
| Total | $ | 0.22 | $ | 0.91 | |||||||||||||||||||
nm - not meaningful
Sales
Sales decreased $46.5 million or 5.2% in the three months ended March 31, 2023 compared to the three months ended March 31, 2022. The acquisition of APM increased sales by 10.8%, which was more than offset by the impacts of lower global demand and customer destocking as well as the unfavorable impact of foreign currency.
Cost of sales
As a percent of sales, cost of sales decreased from 71.5% to 70.7% in the three months ended March 31, 2022 to March 31, 2023, primarily as a result of mix along with raw material deflation, partially offset by higher restructuring charges in the first quarter 2023.
Selling and administrative expense
Selling and administrative expense increased $38.3 million during the three months ended March 31, 2023 compared to the three months ended March 31, 2022, primarily driven by the acquisition of APM along with higher restructuring charges associated with 2023 actions taken in response to lower global demand.
14 AVIENT CORPORATION
Interest expense, net
Interest expense, net increased $11.9 million in the three months ended March 31, 2023 compared to the three months ended March 31, 2022 related to due to new debt financing associated with the APM Acquisition and the impact of higher interest rates on our variable term debt.
Income taxes
During the three months ended March 31, 2023, the Company’s effective tax rate was 26.6% versus 23.5% for the three months ended March 31, 2022. The income tax rate increase is primarily due to the higher tax expense associated with valuation allowances, and a higher rate effect of foreign withholding tax for the three months ended March 31, 2023 compared to the three months ended March 31, 2022. This increase was partially offset by favorable permanent tax items for the three months ended March 31, 2023 compared to the three months ended March 31, 2022.
SEGMENT INFORMATION
Avient has two reportable segments: (1) Color, Additives and Inks; and (2) Specialty Engineered Materials. As a result of the agreement to divest the Distribution business segment, we have removed Distribution as a separate reportable segment and its results are presented as a discontinued operation. Historical information has been retrospectively adjusted to reflect these changes. Discontinued operations are further discussed in Note 3,
Discontinued Operations
, to the accompanying condensed consolidated financial statements.
Operating income is the primary measure that is reported to our chief operating decision maker (CODM) for purposes of allocating resources to the segments and assessing their performance. Operating income at the segment level does not include: corporate general and administrative expenses that are not allocated to segments; intersegment sales and profit eliminations; charges related to specific strategic initiatives such as the consolidation of operations; restructuring activities, including employee separation costs resulting from personnel reduction programs, plant closure and phase-in costs; executive separation agreements; share-based compensation costs; asset impairments; environmental remediation costs, along with related gains from insurance recoveries, and other liabilities for facilities no longer owned or closed in prior years; actuarial gains and losses associated with our pension and other post-retirement benefit plans; and certain other items that are not included in the measure of segment profit or loss that is reported to and reviewed by our CODM. These costs are included in Corporate.
Sales and Operating Income —
The three months ended March 31, 2023 compared to the three months ended March 31, 2022
:
| Three Months Ended March 31, |
Variances — Favorable
(Unfavorable) |
||||||||||||||||||||||
| (Dollars in millions) | 2023 | 2022 | Change | % Change | |||||||||||||||||||
| Sales: | |||||||||||||||||||||||
| Color, Additives and Inks | $ | 537.0 | $ | 649.5 | $ | (112.5) | (17.3) | % | |||||||||||||||
|
Specialty Engineered Materials
|
309.7 | 243.1 | 66.6 | 27.4 | % | ||||||||||||||||||
| Corporate | (1.0) | (0.4) | (0.6) | (150.0) | % | ||||||||||||||||||
| Total Sales | $ | 845.7 | $ | 892.2 | $ | (46.5) | (5.2) | % | |||||||||||||||
| Operating income: | |||||||||||||||||||||||
| Color, Additives and Inks | $ | 65.6 | $ | 94.5 | $ | (28.9) | (30.6) | % | |||||||||||||||
|
Specialty Engineered Materials
|
43.1 | 38.3 | 4.8 | 12.5 | % | ||||||||||||||||||
| Corporate | (51.6) | (30.6) | (21.0) | (68.6) | % | ||||||||||||||||||
| Total Operating Income | $ | 57.1 | $ | 102.2 | $ | (45.1) | (44.1) | % | |||||||||||||||
Color, Additives and Inks
Sales decreased $112.5 million or 17.3% in the three months ended March 31, 2023 compared to the three months ended March 31, 2022 primarily driven by global demand and customer destocking and the unfavorable impact of foreign currency.
Operating income decreased $28.9 million in the three months ended March 31, 2023 compared to the three months ended March 31, 2022 driven by lower global demand and customer destocking.
15 AVIENT CORPORATION
Specialty Engineered Materials
Sales increased $66.6 million or 27.4% in the three months ended March 31, 2023 compared to the three months ended March 31, 2022. The acquisition of APM increased sales by 39.7%, which was partially offset by the impacts of lower global demand and customer destocking.
Operating income increased $4.8 million in the three months ended March 31, 2023 as compared to the three months ended March 31, 2022, as the impact of APM more than offset the aforementioned lower demand and customer destocking.
Corporate
Corporate costs increased $21.0 million or 68.6% in the three months ended March 31, 2023 as compared to the three months ended March 31, 2022 primarily due to higher restructuring charges in the first quarter of 2023.
Liquidity and Capital Resources
Our objective is to finance our business through operating cash flow and an appropriate mix of debt and equity. By laddering the maturity structure, we avoid concentrations of debt maturities, reducing liquidity risk. We may from time to time seek to retire or purchase our outstanding debt with cash and/or exchanges for equity securities, in open market purchases, privately negotiated transactions or otherwise. We may also seek to repurchase our outstanding common shares. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved have been and may continue to be material.
The following table summarizes our liquidity as of March 31, 2023 and December 31, 2022:
| (In millions) | As of March 31, 2023 | As of December 31, 2022 | |||||||||
| Cash and cash equivalents | $ | 582.7 | $ | 641.1 | |||||||
| Revolving credit availability | 226.8 | 246.2 | |||||||||
| Liquidity | $ | 809.5 | $ | 887.3 | |||||||
As of March 31, 2023, approximately 58% of the Company’s cash and cash equivalents resided outside the United States.
Expected sources of cash needed to satisfy cash requirements for 2023 include our cash on hand, cash from operations and available liquidity under our revolving credit facility, if needed. Expected uses of cash for 2023 include interest payments, cash taxes, dividend payments, share repurchases, environmental remediation costs and capital expenditures.
Cash Flows
The following describes the significant components of cash flows from operating, investing and financing activities for the three months ended March 31, 2023 and 2022.
Operating Activities
—
In the three months ended March 31, 2023, net cash used by operating activities was $22.2 million as compared to net cash provided by operating activities of $18.9 million for the three months ended March 31, 2022, driven primarily by lower earnings.
Investing Activities
—
Net cash used by investing activities during the three months ended March 31, 2023 of $13.0 million reflects the impact of capital expenditures, offset by proceeds received from the divestiture of the Distribution business.
Net cash used by investing activities during the three months ended March 31, 2022 of $13.3 million reflects capital expenditures.
Financing Activities
—
Net cash provided by financing activities for the three months ended March 31, 2023 of $25.6 million primarily reflects $22.5 million of dividends paid.
Net cash used by financing activities for the three months ended March 31, 2022 of $43.8 million primarily reflects $21.7 million of dividends paid, repayment of debt of $2.4 million, and repurchase of our outstanding common shares of $15.8 million.
16 AVIENT CORPORATION
Debt
As of March 31, 2023, our principal amount of debt totaled $2,215.5 million. Aggregate maturities of the principal amount of debt for the current year, next four years and thereafter, are as follows:
| (In millions) | ||||||||
| 2023 | $ | 1.4 | ||||||
| 2024 | 2.2 | |||||||
| 2025 | 652.2 | |||||||
| 2026 | 427.4 | |||||||
| 2027 | 0.4 | |||||||
| Thereafter | 1,131.9 | |||||||
| Aggregate maturities | $ | 2,215.5 | ||||||
As of March 31, 2023, we were in compliance with all financial and restrictive covenants pertaining to our debt. For additional information regarding our debt, please see Note 9,
Financing Arrangements
to the accompanying condensed consolidated financial statements
.
Derivatives and Hedging
We are exposed to market risks, such as changes in foreign currency exchange rates and interest rates. To manage the volatility related to these exposures we may enter into various derivative transactions. For additional information regarding our derivative instruments, please see Note 12,
Derivatives and Hedging
to the accompanying condensed consolidated financial statements
.
Material Cash Requirements
We have future obligations under various contracts relating to debt and interest payments, derivative instruments, operating leases, pension and post-retirement benefit plans and purchase obligations. During the three months ended March 31, 2023, there were no material changes to these obligations as reported in our Annual Report on Form 10-K for the year ended December 31, 2022.
17 AVIENT CORPORATION
CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS
In this Quarterly Report on Form 10-Q, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historic or current facts. They use words such as "will," “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning in connection with any discussion of future operating or financial condition, performance and/or sales. In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and environmental liabilities; and financial results. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
•
disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
•
the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
•
the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without limitation, any supply chain and logistics issues;
•
changes in laws and regulations regarding plastics in jurisdictions where we conduct business;
•
fluctuations in raw material prices, quality and supply, and in energy prices and supply;
•
production outages or material costs associated with scheduled or unscheduled maintenance programs;
•
unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
•
an inability to raise or sustain prices for products or services;
•
our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
•
information systems failures and cyberattacks;
•
amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions;
•
our ability to achieve strategic objectives and successfully integrate acquisitions, including Avient Protective Materials (APM);
•
other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation and any recessionary conditions; and
•
other factors described in our Annual Report on Form 10-K for the year ended December 31, 2022 under Item 1A, “Risk Factors.”
We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law. You are advised, however, to consult any further disclosures we make on related subjects in our reports on Forms 10-Q, 8-K and 10-K filed with the Securities and Exchange Commission. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.
ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes to exposures to market risk as reported in our Annual Report on Form 10-K for the year ended December 31, 2022.
18 AVIENT CORPORATION
ITEM 4.
CONTROLS AND PROCEDURES
Disclosure controls and procedures
Avient’s management, under the supervision of and with the participation of its Chief Executive Officer and its Chief Financial Officer, has evaluated the effectiveness of the design and operation of Avient’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this Quarterly Report. Based upon this evaluation, Avient’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report, its disclosure controls and procedures were effective.
Changes in internal control over financial reporting
There were no changes in Avient’s internal control over financial reporting during the quarter ended March 31, 2023 that materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.
PART II — OTHER INFORMATION
ITEM 1.
LEGAL PROCEEDINGS
Information regarding certain legal proceedings can be found in Note 11,
Commitments and Contingencies
to the accompanying condensed consolidated financial statements and is incorporated by reference herein.
ITEM 1A.
RISK FACTORS
We face a number of risks that could adversely affect our business, results of operations, financial position or cash flows. A discussion of our risk factors can be found in Item 1A, Risk factors, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. During the first quarter ended March 31, 2023, there were no material changes to our previously disclosed risk factors.
ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The table below sets forth information regarding the repurchase of shares of our common shares during the period indicated.
| Period | Total Number of Shares Purchased | Weighted Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Program |
Maximum Number of Shares that May Yet be Purchased Under the Program
(1)
|
|||||||||||||||||||
| January 1 to January 31 | — | $ | — | — | 4,957,472 | ||||||||||||||||||
| February 1 to February 28 | — | — | — | 4,957,472 | |||||||||||||||||||
| March 1 to March 31 | — | — | — | 4,957,472 | |||||||||||||||||||
| Total | — | $ | — | — | |||||||||||||||||||
(1)
Our Board of Directors approved a common share repurchase program authorizing Avient to purchase its common shares in August 2008, which share repurchase authorization has been subsequently increased from time to time. On December 9, 2020, we announced that we would increase our share buyback by an additional 5.0 million shares. As of March 31, 2023, approximately 5.0 million shares remained available for purchase under these authorizations, which have no expiration. Purchases of common shares may be made by open market purchases or privately negotiated transactions and may be made pursuant to Rule 10b5-1 plans and accelerated share repurchases.
19 AVIENT CORPORATION
ITEM 6.
EXHIBITS
EXHIBIT INDEX
| Exhibit No. | Exhibit Description | |||||||
| 101.INS | Inline XBRL Instance Document | |||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | |||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||||
|
†
|
Certain exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K and will be provided to the Securities and Exchange Commission upon request.
|
|||||||
| ** | Filed herewith. | |||||||
20 AVIENT CORPORATION
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| May 3, 2023 | AVIENT CORPORATION | |||||||
| /s/ Jamie A. Beggs | ||||||||
|
Jamie A. Beggs
Senior Vice President and Chief Financial Officer |
||||||||
21 AVIENT CORPORATION
TABLE OF CONTENTS
Part I Financial InformationprintItem 1. Financial StatementsprintNote 1 Basis Of PresentationprintNote 2 Business CombinationsprintNote 3 Discontinued OperationsprintNote 4 Goodwill and Intangible AssetsprintNote 5 Employee Separation and Restructuring CostsprintNote 6 Inventories, NetprintNote 7 Property, NetprintNote 8 Income TaxesprintNote 9 Financing ArrangementsprintNote 10 Segment InformationprintNote 11 Commitments and ContingenciesprintNote 12 Derivatives and HedgingprintItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsprintItem 3. Quantitative and Qualitative Disclosures About Market RiskprintItem 4. Controls and ProceduresprintPart II Other InformationprintItem 1. Legal ProceedingsprintItem 1A. Risk FactorsprintItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsprintItem 6. Exhibitsprint